
Sign up to save your podcasts
Or


A panel of hematology leaders discusses the latest in ALL and T-cell ALL therapy, including TKI+blina combinations, venetoclax strategies, and the emerging role of CD7 CAR T-cell therapies in reshaping treatment paradigms.
By Rahul Banerjee, MD4.8
2727 ratings
A panel of hematology leaders discusses the latest in ALL and T-cell ALL therapy, including TKI+blina combinations, venetoclax strategies, and the emerging role of CD7 CAR T-cell therapies in reshaping treatment paradigms.

136 Listeners

320 Listeners

495 Listeners

75 Listeners

118 Listeners

26 Listeners

1,158 Listeners

187 Listeners

22 Listeners

364 Listeners

54 Listeners

136 Listeners

48 Listeners

189 Listeners

30 Listeners